Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Non-Malignant Channel: Hemophilia

Explore the latest updates and expert interviews
Latest Videos Conferences Topics Features Podcasts

Welcome to The Hemophilia Channel

Reporting from key international congresses and speaking with world-leading experts, VJHemOnc brings you the latest exciting advances in hemophilia research, diagnosis and care. The Hemophilia Channel delivers regular video interviews, roundtable discussions, podcasts and feature articles, so that you can keep up-to-date with all the practice-changing developments in hemophilia.

Explore The Hemophilia Channel to learn about the latest clinical trial updates, novel therapeutics and regimens, diagnostic advances and optimal management across the hemophilia space.

Conferences

ASH 2024
ISTH 2024
BSH 2024
ASH 2023
ISTH 2023
EHA 2023
2:23
Investigating novel variants in individuals with rare coagulation disorders
Amy Shapiro • 7 Dec 2024
1:22
The use of RNA interference-based therapies like fitusiran in hemophilia treatment
Tadashi Matsushita • 7 Dec 2024
3:28
Partners Physician Academy: the effectiveness of a program to address gaps in hemostasis training
Amy Shapiro • 7 Dec 2024
4:23
The current approaches to prophylaxis in hemophilia and tailoring treatment to the individual
Amy Shapiro • 7 Dec 2024
View All Videos
4:31
The importance of improving joint and muscle health in patients with hemophilia
Rungrote Natesirinilkul • 16 Jun 2024
4:14
Key challenges in hemophilia management and diagnosis in resource-constrained countries
Rungrote Natesirinilkul • 16 Jul 2024
5:54
Addressing the risk of cancer after AAV vector dosing in patients with hemophilia
Radek Kaczmarek • 22 Jul 2024
5:08
The importance of optimizing liver health before gene therapy and how this is accomplished
Radek Kaczmarek • 22 Jul 2024
View All Videos
1:06
The importance of shared-decision making when treating infants with hemophilia
Jayashree Motwani • 28 Apr 2024
2:40
The safety & efficacy of emicizumab in patients under 18 months with hemophilia A
Eman Hassan • 28 Apr 2024
2:24
Primary prevention against atherosclerosis in patients with hemophilia
Beverley Hunt • 29 Apr 2024
1:39
Considering the use of gene therapy in severe inherited thrombophilia
Beverley Hunt • 29 Apr 2024
View All Videos
1:08
The current landscape of hemophilia treatment: an update from ASH 2023
Glaivy Batsuli • 10 Dec 2023
1:18
Unmet needs in hemophilia treatment
Glaivy Batsuli • 10 Dec 2023
1:11
Improving outcomes for hemophilia patients through the implementation of gene therapies
Evelien Krumb • 12 Dec 2023
1:27
The impact of emicizumab on the hemophilia treatment landscape
Glaivy Batsuli • 10 Dec 2023
View All Videos
2:15
Emicizumab prophylaxis instead of immunosuppressive therapy in patients with acquired hemophilia A
Andreas Tiede • 25 Jun 2023
1:12
Promising novel agents for hemophilia A/B: gene therapies and extended half-life products
Azusa Nagao • 27 Jun 2023
4:01
Emicizumab for hemophilia A: interim analysis of the real-world EMIIL study
Johannes Oldenburg • 25 Jun 2023
1:46
Unmet needs in hemophilia B: treating patients who develop inhibitors
Katharina Holstein • 25 Jun 2023
View All Videos
1:17
Emerging strategies to support patients with hemophilia A
Riitta Lassila • 10 Jun 2023
0:55
The importance of thrombosis and hemostasis in hematology & hot topics in hemophilia research
Riitta Lassila • 10 Jun 2023
1:06
Overview of the diagnostic work-up for hemophilia
Riitta Lassila • 10 Jun 2023
1:43
Quality of life in patients with hemophilia: the impact of bleeds & the benefits of gene therapy
Riitta Lassila • 10 Jun 2023
View All Videos

Topics

Gene therapy
Treatment
Immuno-Oncology
Trial Updates
2:51
The safety and efficacy of currently approved gene therapies for hemophilia
Radek Kaczmarek • 31 Jul 2025
1:09
Barriers and unanswered questions in the field of gene therapy for hemophilia
Radek Kaczmarek • 31 Jul 2025
5:27
AAV vector integration events and malignancy surveillance in hemophilia gene therapy recipients
Radek Kaczmarek • 31 Jul 2025
3:07
Why has the uptake of gene therapy in hemophilia been less than expected?
Radek Kaczmarek • 31 Jul 2025
View All Videos
2:51
The safety and efficacy of currently approved gene therapies for hemophilia
Radek Kaczmarek • 31 Jul 2025
1:09
Barriers and unanswered questions in the field of gene therapy for hemophilia
Radek Kaczmarek • 31 Jul 2025
5:27
AAV vector integration events and malignancy surveillance in hemophilia gene therapy recipients
Radek Kaczmarek • 31 Jul 2025
3:07
Why has the uptake of gene therapy in hemophilia been less than expected?
Radek Kaczmarek • 31 Jul 2025
View All Videos
1:06
ISTH 2024 highlights: promising upcoming treatments for hemophilia
Matteo Luciani • 9 Jul 2024
6:48
An overview of the remaining challenges for patients with hemophilia
Matteo Luciani • 9 Jul 2024
2:08
An overview of ongoing clinical trials for the treatment of hemophilia
Omolade Awodu • 3 Jul 2024
1:27
The impact of emicizumab on the hemophilia treatment landscape
Glaivy Batsuli • 10 Dec 2023
View All Videos
3:25
Phase III study of rurioctocog alfa pegol in PUPs with severe hemophilia A: safety & efficacy data
Robert Sidonio Jr • 14 Jul 2025
4:31
Annualized bleeding rates in patients with hemophilia A/B and inhibitors treated with concizumab
Amy Shapiro • 7 Dec 2024
1:27
AKATSUKI study: emicizumab & immune tolerance induction in hemophilia A with factor VIII inhibitors
Tadashi Matsushita • 7 Dec 2024
1:15
FRONTIER4: safety & efficacy of Mim8 prophylaxis administered once every two weeks for hemophilia A
Tadashi Matsushita • 7 Dec 2024
View All Videos
The content of VJHemOnc is intended for healthcare professionals